Supplementary Section 3)
The MIC compounds work to break down fat in the liver, promoting fat metabolism and assisting in weight loss
The drug has negligible effects on platelet function and gastric mucosa, distinguishing it physiologically from NSAIDs
Delve into the scientific nuances of the GLP-1 Agonist, Wegovy, and the GLP/GIP Agonist, Zepbound, as they unravel their roles in treating lipedema
If you frequently struggle with adherence, discuss this openly with your GP or diabetes specialist nurse, as they may suggest strategies tailored to your lifestyle or consider whether alternative treatment regimens might be more suitable for your circumstances
Malabsorption disorders : Patients with conditions like Crohns disease, celiac disease, or pernicious anemia that affect the absorption of nutrients may require more frequent injections, approximately every 4-8 weeks